Hyperuricemia-Pipeline Review, H1 2016 Hyperuricemia-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Hyperuricemia-Pipeline Review, H1 2016’, provides an overview of the Hyperuricemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperuricemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers… Read More »
Herpes Zoster Shingles-Pipeline Review, H1 2016 Herpes Zoster (Shingles)-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Herpes Zoster (Shingles)-Pipeline Review, H1 2016’, provides an overview of the Herpes Zoster (Shingles) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Herpes Zoster (Shingles), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration… Read More »
Choroidal Neovascularization-Pipeline Review, H1 2016 Choroidal Neovascularization-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Choroidal Neovascularization-Pipeline Review, H1 2016’, provides an overview of the Choroidal Neovascularization pipeline landscape. The report provides comprehensive information on the therapeutics under development for Choroidal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.… Read More »
Pancreatitis-Pipeline Review, H1 2016 Pancreatitis-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Pancreatitis-Pipeline Review, H1 2016’, provides an overview of the Pancreatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers… Read More »
Acromegaly-Pipeline Review, H1 2016 Acromegaly-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Acromegaly-Pipeline Review, H1 2016’, provides an overview of the Acromegaly pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acromegaly, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers… Read More »
Uveal Melanoma-Pipeline Review, H1 2016 Uveal Melanoma-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Uveal Melanoma-Pipeline Review, H1 2016’, provides an overview of the Uveal Melanoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.… Read More »
West Nile Virus Infections-Pipeline Review, H1 2016 West Nile Virus Infections-Pipeline Review, H1 2016 Global Markets Direct’s, ‘West Nile Virus Infections-Pipeline Review, H1 2016’, provides an overview of the West Nile Virus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for West Nile Virus Infections, complete with analysis by stage of development, drug target, mechanism of action… Read More »
Oligodendroglioma-Pipeline Review, H1 2016 Oligodendroglioma-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Oligodendroglioma-Pipeline Review, H1 2016’, provides an overview of the Oligodendroglioma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oligodendroglioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers… Read More »
Chlamydia Infections-Pipeline Review, H1 2016 Chlamydia Infections-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Chlamydia Infections-Pipeline Review, H1 2016’, provides an overview of the Chlamydia Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chlamydia Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.… Read More »
Fragile X Syndrome-Pipeline Review, H1 2016 Fragile X Syndrome-Pipeline Review, H1 2016 Global Markets Direct’s, ‘Fragile X Syndrome-Pipeline Review, H1 2016’, provides an overview of the Fragile X Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fragile X Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration… Read More »
